Inferenz launches AI agent to score hospice eligibility and rank admissions

Inferenz has released a hospice eligibility AI agent inside its Caregence platform to automate referral screening and admission prioritization for providers. The company says the system can cut review time from 30-90 minutes to about five minutes while creating an audit trail for compliance teams.

Why it matters: - Hospice intake teams often have to decide quickly whether a patient meets eligibility rules and should be admitted next. - Inferenz says the new agent can shorten a review that typically takes 30-90 minutes to about five minutes. - Faster and more consistent screening can reduce compliance risk and help providers avoid losing qualifying patients to faster-moving competitors.

What happened: - Inferenz announced the general availability of its Hospice Eligibility AI Agent on Aug. 24, 2026. - The product is part of the company’s Caregence™ agentic AI platform for healthcare providers. - The agent automates hospice referral eligibility screening and admission prioritization. - The launch was announced from Round Rock, Texas.

The details: - The eligibility workflow pulls referral packets, physician certifications, encounter notes, admission forms and other clinical documentation. - Document Intelligence extracts structured values from the source records. - The AI agent applies provider-specific scoring rules written and edited in plain language by clinical staff. - The system returns one of three outcomes: Eligible, Pending Review or Ineligible. - The agent also provides the reasoning behind each determination. - The second workflow scores eligible referrals against an organization’s historical admission data. - The ranking model weighs diagnosis fit, referral source, geography and caregiver availability. - The system produces a referral-to-admission conversion probability to prioritize the queue automatically. - Every step is timestamped to create an audit trail for compliance review. - The company says a CMS reviewer can follow the record without reconstructing the decision after the fact. - Inferenz also said a typical 25-person intake team can properly review about 75 referrals a day, while some days bring 500. - The company says reviewers can score inconsistently under that pressure, which can create clawback risk and compliance exposure.

Between the lines: - The product is aimed at a high-friction part of hospice operations where speed and defensibility matter at the same time. - The emphasis on provider-authored scoring rules suggests the company is positioning the tool as decision support rather than a replacement for clinical judgment. - The timing and audit features point to a broader selling pitch around compliance as much as automation. - Jalindar Karande, Director-Solutions at Inferenz, said the agent removes a bottleneck so coordinators can see a ranked, defensible determination in minutes instead of losing a qualifying patient to whoever called first.

What's next: - The Hospice Eligibility Agent is joining a broader Caregence™ portfolio that already includes AI agents for prior authorization, revenue cycle management, predictive caregiver-to-patient matching and real-time risk analysis. - Inferenz says the agents use an interoperable, MCP-based architecture that connects to existing EHR, CRM or intake portal systems without a migration. - The company directs readers to explore the Caregence™ agent portfolio for more information. - Inferenz operates from Ahmedabad and Pune, India, and Round Rock, Texas. - The company works across healthcare, insurance and hi-tech and says its iDAR™ framework is designed to move organizations from data to AI to ROI. - Contact: Adarsh Adwait, Inferenz, +1 609-721-0797. - Social links: LinkedIn, Instagram, YouTube, Medium.